FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) e estimate Rivian’s stock price to be $140.00 per share. Our estimated stock ...

Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to ...

You may recognize him as Uncle Frank Hillard from Mrs. Doubtfire, and if you do, you probably wouldn’t recognize him now.

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...

Nyxoah's disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and FDA's decision is expected in Q1 ...

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...

The CDC reported over double the cases of norovirus, commonly known as stomach flu, as the peak of the virus' season begins.